Showing 1 - 4 results of 4 for search 'A.H. Varey' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • A.H. Varey
Showing 1 - 4 results of 4 for search 'A.H. Varey', query time: 0.03s Refine Results
  1. 1
    Validation of the Melanoma Institute Australia Prediction Tool for Sentinel Node Metastasis Risk Amongst Patients with Cutaneous Head and Neck Melanoma

    Validation of the Melanoma Institute Australia Prediction Tool for Sentinel Node Metastasis Risk Amongst Patients with Cutaneous Head and Neck Melanoma by A.T. Li, S.N. Lo, A.H. Varey, S. Ch'ng

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Long-term survival of melanoma patients according to primary tumour thickness – an Australian population-based study

    Long-term survival of melanoma patients according to primary tumour thickness – an Australian population-based study by A.H. Varey, S.N. Lo, G.J. Williams, A.E. Cust, R.A. Scolyer, J.F. Thompson

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Analysis of the long-term survival of patients with thin melanomas using comprehensive, population-based Australian data

    Analysis of the long-term survival of patients with thin melanomas using comprehensive, population-based Australian data by A.H. Varey, S.N. Lo, G.J. Williams, A.E. Cust, D. Ollila, R.A. Scolyer, J.F. Thompson

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy

    Survival Outcomes in T3N0 versus N1 in Head and Neck Cutaneous Squamous Cell Carcinoma – Implications for Neoadjuvant Immune Checkpoint Inhibitor Immunotherapy by A.E. Yung, Y.J. Jeong, A.H. Varey, S.N. Lo, R. Gupta, R. Wu, M. Dunn, J.H. Lee, T.-H.H. Low, K.F. Shannon, J.R. Clark, S. Ch'ng

    Published 2024-01-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs